James P. Allison Institute™

Enhance diagnosis and treatment precision through imaging and pathology insights 

By integrating vast imaging and pathology data, the institute will enable faster, more accurate diagnoses and personalized treatment plans—ensuring that patients receive the right care at the right time.

Discover new therapies by understanding cancer at the cellular level 

The institute unites MD Anderson’s unmatched basic science and bioinformatics teams with global experts in machine learning to decode cancer at its most fundamental level, accelerating the discovery of new drug targets. Single-cell analytics help researchers to uncover how cancer begins and evolves, leading to earlier detection and the development of highly targeted therapies that improve survival and reduce side effects.

Accelerate personalized medicine with AI-driven drug discovery 

By combining clinical, research and imaging capabilities with scientific collaborations—including aerospace and physics domains—the institute will drive personalized, adaptive treatment strategies and uncover novel therapies.

Improve public health through data-informed cancer intervention models 

By modeling cancer’s impact across communities, the institute guides smarter population health strategies—helping to reduce disparities, to improve access and to extend the benefits of care beyond the clinic. From local to global scales, these models will guide policy, improve public health, and expand MD Anderson’s reach in Texas and beyond.

Develop automated approaches to increase access, safety and quality in cancer care 

Data science innovations can solve operational challenges—from cybersecurity to patient scheduling. The institute will develop automated systems and collaborate with industry to enhance the safety, quality, and convenience of care for every patient.